Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The chronic myeloproliferative disorders: clonality and clinical heterogeneity.

Seminars in hematology - 1 Apr 2004

Spivak Jerry L

Abstract excerpt

The chronic myeloproliferative disorders (MPD), polycythemia vera (PV), chronic idiopathic myelofibrosis (IMF), essential thrombocytosis (ET), and chronic myelogenous leukemia (CML), are thought to be clonal disorders arising in a multipotent hematopoietic progenitor cell. However, establishing the diagnosis of an MPD other than CML is problematic due to a lack of clinically applicable clonal markers....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelets
Share to GPI-Linked Proteins
Share to Isoantigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Megakaryocytes

Share to Myeloproliferative Disorders

Share to Receptors, Cytokine

Share to Receptors, Thrombopoietin

Source

Identifiers

PMID: 15190515
DOI: 10.1053/j.seminhematol.2004.02.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The chronic myeloproliferative disorders: clonality and clinical heterogeneity.PMID 15190515Read ↗

The human myeloproliferative disorders : molecular pathogenesis and clonal heterogeneitySemantic proximity Read ↗

Molecular pathogenesis of the myeloproliferative neoplasms.Semantic proximity Read ↗

Clonal Hematopoiesis and Mutations of Myeloproliferative NeoplasmsSemantic proximity Read ↗

Recent advances in understanding myelofibrosis and essential thrombocythemiaSemantic proximity Read ↗

Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice.Semantic proximity Read ↗

Molecular basis and clonal evolution of myeloproliferative neoplasms.Semantic proximity Read ↗

Genotype-phenotype interactions in the myeloproliferative neoplasms.Semantic proximity Read ↗

Myeloproliferative disordersSemantic proximity Read ↗

Clonal hematopoiesis in hematological disorders: Three different scenarios.Semantic proximity Read ↗

Stem cell defects in Philadelphia chromosome negative chronic myeloproliferative disorders: a phenotypic and molecular puzzle?Semantic proximity Read ↗

Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the game.Semantic proximity Read ↗

Targets in MPNs and potential therapeutics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.